5:35 pm: The Wizards have applied for a disabled player exception for Whitmore, a league source tells Michael Scotto of HoopsHype (Twitter link). The team does have an opening on its standard roster to potentially sign a free agent, though a contract using the DPE would only be able to cover the rest of the season.
4:12 pm: Wizards forward Cam Whitmore has been formally ruled out for the remainder of the 2025/26 season due to a blood clot in his right shoulder, the team announced on Thursday (Twitter link).
According to the Wizards, Whitmore has begun the recovery process for the upper-extremity deep vein thrombosis he was diagnosed with on December 23.
A one-and-done prospect at Villanova in 2022/23, Whitmore was viewed as a potential top-five pick in the 2023 draft, but ultimately fell to No. 20, where he was selected by the Rockets. In two seasons with Houston, the 21-year-old played a limited role off the bench but showed some promise as a scorer, averaging 10.8 points in 17.4 minutes per contest with a shooting line of .449/.357/.707.
Recognizing that Whitmore wasn’t part of their long-term plans, the Rockets traded him to the Wizards during the 2025 offseason in exchange for a pair of second-round picks. Through his first 21 games in Washington D.C., he averaged 9.2 PPG on .456/.286/.742 shooting.
There’s no indication at this point that the blood clot in his shoulder will threaten Whitmore’s career. Victor Wembanyama, Brandon Ingram, and Ausar Thompson are among the current NBA players who have fully recovered and return to action after facing similar diagnoses.
As cap expert Yossi Gozlan notes (via Twitter), January 15 is the final day for NBA teams to apply for disabled player exceptions. A DPE for Whitmore would be worth $1,769,880, half of his ’25/26 salary.